Arcosa Inc
NYSE:ACA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
75.78
111.57
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Arcosa Inc
Wall Street
Price Targets
ACA Price Targets Summary
Arcosa Inc
According to Wall Street analysts, the average 1-year price target for
ACA
is 118.32 USD
with a low forecast of 106.05 USD and a high forecast of 152.25 USD.
ACA Last Price Targets
Arcosa Inc
The latest public price target was made on Oct 29, 2024 by
Adam Seiden
from
Barclays
,
who expects
ACA
stock to
rise by 8%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Adam Seiden
Barclays
|
106
USD
Upside 8% |
1 month ago
Oct 29, 2024
|
Arcosa initiated with an Overweight at Barclays
TheFly
|
|
Trey Grooms
Stephens
|
96
USD
Downside 2% |
4 months ago
Aug 7, 2024
|
Arcosa upgraded to Overweight at Stephens on benefits of portfolio actions
TheFly
|
Garik Shmois
Loop Capital Markets
|
110
USD
Upside 12% |
4 months ago
Aug 5, 2024
|
Arcosa price target raised to $110 from $95 at Loop Capital
TheFly
|
Brent Thielman
D.A. Davidson
|
110
USD
Upside 12% |
7 months ago
May 17, 2024
|
Arcosa price target raised to $110 from $105 at DA Davidson
TheFly
|
|
Brent Thielman
D.A. Davidson
|
105
USD
Upside 7% |
7 months ago
May 6, 2024
|
Arcosa (ACA) PT Raised to $105 at DA Davidson
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ACA's stock price target?
Price Target
118.32
USD
According to Wall Street analysts, the average 1-year price target for
ACA
is 118.32 USD
with a low forecast of 106.05 USD and a high forecast of 152.25 USD.
What is Arcosa Inc's Revenue forecast?
Projected CAGR
12%
For the last 7 years the
compound annual growth rate for
Arcosa Inc's revenue is
4%.
The projected
CAGR
for the next 3 years is
12%.
What is Arcosa Inc's Operating Income forecast?
Projected CAGR
33%
For the last 7 years the
compound annual growth rate for
Arcosa Inc's operating income is
-1%.
The projected
CAGR
for the next 3 years is
33%.
What is Arcosa Inc's Net Income forecast?
Projected CAGR
18%
For the last 7 years the
compound annual growth rate for
Arcosa Inc's net income is
4%.
The projected
CAGR
for the next 3 years is
18%.
You don't have any saved screeners yet
